Erythropoietin (EPO), a hematopoietic cytokine, has been studied for its potential therapeutic effects in many neurodegenerative diseases, including Parkinson’s disease, AD, amyotrophic lateral sclerosis, spinal cord injury, brain ischemia, hypoxia, and hyperoxia [5]. The gene discussed is EPO; the disease is neurodegenerative disease.